Kidney cancer, Renal cell cancer
Results
Phase 3
This trial compared nivolumab and ipilimumab with a standard treatment called sunitinib for kidney cancer.
It was for people with a type of kidney cancer called renal cell cancer that had grown outside the kidney or spread to another part of the body.
Recruitment start: 1 October 2014
Recruitment end: 1 February 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Hawkins
Ono Pharmaceutical
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 19 February 2019
CRUK internal database number: 12643
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
